861 related articles for article (PubMed ID: 16921376)
21. Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer.
Buness A; Kuner R; Ruschhaupt M; Poustka A; Sültmann H; Tresch A
Bioinformatics; 2007 Sep; 23(17):2273-80. PubMed ID: 17599933
[TBL] [Abstract][Full Text] [Related]
22. [Histopathologic diagnosis of luminal and basal type breast cancer].
Sarcević B
Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
[TBL] [Abstract][Full Text] [Related]
23. Copy number alterations that predict metastatic capability of human breast cancer.
Zhang Y; Martens JW; Yu JX; Jiang J; Sieuwerts AM; Smid M; Klijn JG; Wang Y; Foekens JA
Cancer Res; 2009 May; 69(9):3795-801. PubMed ID: 19336569
[TBL] [Abstract][Full Text] [Related]
24. Gene expression signature predicts recurrence in lung adenocarcinoma.
Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
[TBL] [Abstract][Full Text] [Related]
25. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
26. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells.
Stindl R
Med Hypotheses; 2008; 71(1):126-40. PubMed ID: 18294777
[TBL] [Abstract][Full Text] [Related]
27. CIN-ful cancers.
Rajagopalan H; Lengauer C
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S65-8. PubMed ID: 15309517
[TBL] [Abstract][Full Text] [Related]
28. Mining gene expression profiles: expression signatures as cancer phenotypes.
Nevins JR; Potti A
Nat Rev Genet; 2007 Aug; 8(8):601-9. PubMed ID: 17607306
[TBL] [Abstract][Full Text] [Related]
29. Challenges in projecting clustering results across gene expression-profiling datasets.
Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
[TBL] [Abstract][Full Text] [Related]
30. Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function.
Li L; McCormack AA; Nicholson JM; Fabarius A; Hehlmann R; Sachs RK; Duesberg PH
Cancer Genet Cytogenet; 2009 Jan; 188(1):1-25. PubMed ID: 19061776
[TBL] [Abstract][Full Text] [Related]
31. Cancer chromosomes in crisis.
DePinho RA; Polyak K
Nat Genet; 2004 Sep; 36(9):932-4. PubMed ID: 15340427
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic instability in young patients with multiple primary cancers.
Keller U; Grabenbauer G; Kuechler A; Sprung CN; Müller E; Sauer R; Distel L
Cancer Genet Cytogenet; 2005 Feb; 157(1):25-32. PubMed ID: 15676143
[TBL] [Abstract][Full Text] [Related]
33. Chromosome instability in neoplasia: chaotic roots to continuous growth.
Gagos S; Irminger-Finger I
Int J Biochem Cell Biol; 2005 May; 37(5):1014-33. PubMed ID: 15743675
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Miller ET; You S; Cadaneanu RM; Kim M; Yoon J; Liu ST; Li X; Kwan L; Hodge J; Quist MJ; Grasso CS; Lewis MS; Knudsen BS; Freeman MR; Garraway IP
BMC Cancer; 2020 May; 20(1):398. PubMed ID: 32380981
[TBL] [Abstract][Full Text] [Related]
35. A molecular signature of metastasis in primary solid tumors.
Ramaswamy S; Ross KN; Lander ES; Golub TR
Nat Genet; 2003 Jan; 33(1):49-54. PubMed ID: 12469122
[TBL] [Abstract][Full Text] [Related]
36. A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis.
Sheltzer JM
Cancer Res; 2013 Nov; 73(21):6401-12. PubMed ID: 24041940
[TBL] [Abstract][Full Text] [Related]
37. In silico pathway analysis based on chromosomal instability in breast cancer patients.
Kour A; Sambyal V; Guleria K; Singh NR; Uppal MS; Manjari M; Sudan M
BMC Med Genomics; 2020 Nov; 13(1):168. PubMed ID: 33167967
[TBL] [Abstract][Full Text] [Related]
38. Difference Makers: Chromosomal Instability versus Aneuploidy in Cancer.
van Jaarsveld RH; Kops GJPL
Trends Cancer; 2016 Oct; 2(10):561-571. PubMed ID: 28741487
[TBL] [Abstract][Full Text] [Related]
39. Prediction of metastasis from low-malignant breast cancer by gene expression profiling.
Thomassen M; Tan Q; Eiriksdottir F; Bak M; Cold S; Kruse TA
Int J Cancer; 2007 Mar; 120(5):1070-5. PubMed ID: 17131339
[TBL] [Abstract][Full Text] [Related]
40. Chromosomal instability is associated with higher expression of genes implicated in epithelial-mesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatin maintenance.
Roschke AV; Glebov OK; Lababidi S; Gehlhaus KS; Weinstein JN; Kirsch IR
Neoplasia; 2008 Nov; 10(11):1222-30. PubMed ID: 18953431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
